Tapewire

Nasdaq · USD

GH

Guardant Health, Inc.

Export transactions ↓
Tapewire entity
3238
SEC CIK
0001576280
Parsed reports
867

Last 12 months

Inside the activity.

1 purchase rows · 142 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 2025048
Jan 202606
Feb 202600
Mar 202606
Apr 202602
May 2026024
Jun 2026126
Jul 202601
Aug 2026017
Sep 202608
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 21, 2025 Filed Dec 24, 2025 00:25 UTC Exercise / conversionRestricted Stock Units · Derivative 264 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001258394-25-000010 · wk-form4_1766535945.xml · derivative · entry 2

MIGNONE ROBERTO · CIK 0001258394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,976

Underlying: Common Stock · 264 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of October 21, 2024 and the remaining 75% vests monthly for the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
December 21, 2025 Filed Dec 24, 2025 00:25 UTC Exercise / conversionCommon Stock 264 $0.00 $0.00
Disclosure

SEC source: 0001258394-25-000010 · wk-form4_1766535945.xml · nonDerivative · entry 1

MIGNONE ROBERTO · CIK 0001258394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 17, 2025 Filed Dec 18, 2025 23:33 UTC
Tariq MusaDirector
SaleCommon Stock 116 $101.46 $11,769.36
Disclosure

SEC source: 0001968281-25-000015 · wk-form4_1766100817.xml · nonDerivative · entry 1

Tariq Musa · CIK 0001968281 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,993

Read SEC document
December 17, 2025 Filed Dec 18, 2025 23:34 UTC Exercise / conversionRestricted Stock Units · Derivative 232 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001865525-25-000017 · wk-form4_1766100850.xml · derivative · entry 2

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,193

Underlying: Common Stock · 232 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock unit granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024 and the remaining 75% vests monthly for the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
December 17, 2025 Filed Dec 18, 2025 23:34 UTC Exercise / conversionCommon Stock 232 $0.00 $0.00
Disclosure

SEC source: 0001865525-25-000017 · wk-form4_1766100850.xml · nonDerivative · entry 1

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 17, 2025 Filed Jan 22, 2026 22:42 UTC
Chudova DaryaChief Technology Officer
GiftCommon Stock 2,973 $0.00 $0.00
Disclosure

SEC source: 0001977179-26-000004 · wk-form5_1769121738.xml · nonDerivative · entry 3

Chudova Darya · CIK 0001977179 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,397

F2 · shares: The gift of shares has been transferred to a charitable account over which Ms. Chudova has no voting power or control.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:21 UTC
Tariq MusaDirector
Exercise / conversionRestricted Stock Units · Derivative 250 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001968281-25-000013 · wk-form4_1766017289.xml · derivative · entry 2

Tariq Musa · CIK 0001968281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,748

Underlying: Common Stock · 250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly for the three-year period thereafter.

F2 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:21 UTC
Tariq MusaDirector
Exercise / conversionCommon Stock 250 $0.00 $0.00
Disclosure

SEC source: 0001968281-25-000013 · wk-form4_1766017289.xml · nonDerivative · entry 1

Tariq Musa · CIK 0001968281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:19 UTC
Freeman ChrisChief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,402 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001871615-25-000010 · wk-form4_1766017178.xml · derivative · entry 3

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,804

Underlying: Common Stock · 1,402 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:19 UTC
Freeman ChrisChief Commercial Officer
Tax withholdingCommon Stock 594 $102.67 $60,985.98
Disclosure

SEC source: 0001871615-25-000010 · wk-form4_1766017178.xml · nonDerivative · entry 2

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,795

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:19 UTC
Freeman ChrisChief Commercial Officer
Exercise / conversionCommon Stock 1,402 $0.00 $0.00
Disclosure

SEC source: 0001871615-25-000010 · wk-form4_1766017178.xml · nonDerivative · entry 1

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,389

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:20 UTC
Saia John G.Chief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 1,020 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001737840-25-000011 · wk-form4_1766017250.xml · derivative · entry 3

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,039

Underlying: Common Stock · 1,020 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:20 UTC
Saia John G.Chief Legal Officer
Tax withholdingCommon Stock 535 $102.67 $54,928.45
Disclosure

SEC source: 0001737840-25-000011 · wk-form4_1766017250.xml · nonDerivative · entry 2

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,657

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:20 UTC
Saia John G.Chief Legal Officer
Exercise / conversionCommon Stock 1,020 $0.00 $0.00
Disclosure

SEC source: 0001737840-25-000011 · wk-form4_1766017250.xml · nonDerivative · entry 1

Saia John G. · CIK 0001737840 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:18 UTC
EAGLE CRAIGChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,402 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001562135-25-000008 · wk-form4_1766017094.xml · derivative · entry 3

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,804

Underlying: Common Stock · 1,402 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:18 UTC
EAGLE CRAIGChief Medical Officer
Tax withholdingCommon Stock 711 $102.67 $72,998.37
Disclosure

SEC source: 0001562135-25-000008 · wk-form4_1766017094.xml · nonDerivative · entry 2

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,007

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:18 UTC
EAGLE CRAIGChief Medical Officer
Exercise / conversionCommon Stock 1,402 $0.00 $0.00
Disclosure

SEC source: 0001562135-25-000008 · wk-form4_1766017094.xml · nonDerivative · entry 1

EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,718

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:20 UTC
Kalia KumudChief Information Officer
Exercise / conversionRestricted Stock Units · Derivative 637 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001927831-25-000012 · wk-form4_1766017217.xml · derivative · entry 3

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,275

Underlying: Common Stock · 637 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:20 UTC
Kalia KumudChief Information Officer
Tax withholdingCommon Stock 323 $102.67 $33,162.41
Disclosure

SEC source: 0001927831-25-000012 · wk-form4_1766017217.xml · nonDerivative · entry 2

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,679

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:20 UTC
Kalia KumudChief Information Officer
Exercise / conversionCommon Stock 637 $0.00 $0.00
Disclosure

SEC source: 0001927831-25-000012 · wk-form4_1766017217.xml · nonDerivative · entry 1

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,002

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:18 UTC
Eltoukhy HelmyDirector · Co-Chief Executive Officer
SaleCommon Stock 6,620 $104.02 $688,628.29
Disclosure

SEC source: 0001752968-25-000009 · wk-form4_1766017127.xml · nonDerivative · entry 2

Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,047,143

F2 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.020 to $104.055. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:18 UTC
Eltoukhy HelmyDirector · Co-Chief Executive Officer
SaleCommon Stock 83,945 $103.80 $8,713,591.73
Disclosure

SEC source: 0001752968-25-000009 · wk-form4_1766017127.xml · nonDerivative · entry 1

Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,053,763

F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.02 to $104.01. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:17 UTC
Chudova DaryaChief Technology Officer
SaleCommon Stock 5,451 $104.04 $567,131.85
Disclosure

SEC source: 0001977179-25-000010 · wk-form4_1766017060.xml · nonDerivative · entry 1

Chudova Darya · CIK 0001977179 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,012

F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.0401 to $104.0900. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:17 UTC
Bell Michael BrianChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 2,039 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001702824-25-000010 · wk-form4_1766017028.xml · derivative · entry 5

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,078

Underlying: Common Stock · 2,039 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:17 UTC
Bell Michael BrianChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,233 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001702824-25-000010 · wk-form4_1766017028.xml · derivative · entry 4

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,233

Underlying: Common Stock · 1,233 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This represents a restricted stock unit award granted on May 9, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.

F3 · derivative.expiration_date: Not applicable for Restricted Stock Units.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:17 UTC
Bell Michael BrianChief Financial Officer
Tax withholdingCommon Stock 1,659 $102.67 $170,329.53
Disclosure

SEC source: 0001702824-25-000010 · wk-form4_1766017028.xml · nonDerivative · entry 3

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,665

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:17 UTC
Bell Michael BrianChief Financial Officer
Exercise / conversionCommon Stock 2,039 $0.00 $0.00
Disclosure

SEC source: 0001702824-25-000010 · wk-form4_1766017028.xml · nonDerivative · entry 2

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,324

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 00:17 UTC
Bell Michael BrianChief Financial Officer
Exercise / conversionCommon Stock 1,233 $0.00 $0.00
Disclosure

SEC source: 0001702824-25-000010 · wk-form4_1766017028.xml · nonDerivative · entry 1

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,285

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:32 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $32.55 $0.00
Disclosure

SEC source: 0001865525-25-000015 · wk-form4_1765420331.xml · derivative · entry 4

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,029

Underlying: Common Stock · 1,000 shares

Expires 2034-07-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024. The remaining 75% vests monthly for the three-year period thereafter.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:32 UTC SaleCommon Stock 250 $105.00 $26,250.00
Disclosure

SEC source: 0001865525-25-000015 · wk-form4_1765420331.xml · nonDerivative · entry 3

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 797

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:32 UTC SaleCommon Stock 1,000 $105.00 $105,000.00
Disclosure

SEC source: 0001865525-25-000015 · wk-form4_1765420331.xml · nonDerivative · entry 2

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,047

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:32 UTC Exercise / conversionCommon Stock 1,000 $32.55 $32,550.00
Disclosure

SEC source: 0001865525-25-000015 · wk-form4_1765420331.xml · nonDerivative · entry 1

Hidalgo Medina Manuel · CIK 0001865525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:33 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
SaleCommon Stock 4,240 $106.00 $449,440.00
Disclosure

SEC source: 0001753159-25-000006 · wk-form4_1765420401.xml · nonDerivative · entry 9

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares held by Maryam Eskandari 2018 Children's Remainder Trust, Dated 9/25/2018

Disclosed balance after: 168,223

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:33 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
SaleCommon Stock 30,760 $105.34 $3,240,172.27
Disclosure

SEC source: 0001753159-25-000006 · wk-form4_1765420401.xml · nonDerivative · entry 8

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares held by Maryam Eskandari 2018 Children's Remainder Trust, Dated 9/25/2018

Disclosed balance after: 172,463

F3 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.81. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:33 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
SaleCommon Stock 15,000 $104.21 $1,563,124.50
Disclosure

SEC source: 0001753159-25-000006 · wk-form4_1765420401.xml · nonDerivative · entry 7

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares held by Maryam Eskandari 2018 Children's Remainder Trust, Dated 9/25/2018

Disclosed balance after: 203,223

F2 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.00 to $104.75. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:33 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
SaleCommon Stock 4,240 $106.00 $449,440.00
Disclosure

SEC source: 0001753159-25-000006 · wk-form4_1765420401.xml · nonDerivative · entry 6

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares held by AmirAli Talasaz 2018 Children's Remainder Trust, Dated 9/25/2018

Disclosed balance after: 168,223

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:33 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
SaleCommon Stock 30,760 $105.34 $3,240,172.27
Disclosure

SEC source: 0001753159-25-000006 · wk-form4_1765420401.xml · nonDerivative · entry 5

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares held by AmirAli Talasaz 2018 Children's Remainder Trust, Dated 9/25/2018

Disclosed balance after: 172,463

F3 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.81. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:33 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
SaleCommon Stock 15,000 $104.21 $1,563,124.50
Disclosure

SEC source: 0001753159-25-000006 · wk-form4_1765420401.xml · nonDerivative · entry 4

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares held by AmirAli Talasaz 2018 Children's Remainder Trust, Dated 9/25/2018

Disclosed balance after: 203,223

F2 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.00 to $104.75. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:33 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
OtherCommon Stock 193,973 $0.00 $0.00
Disclosure

SEC source: 0001753159-25-000006 · wk-form4_1765420401.xml · nonDerivative · entry 3

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares held by Maryam Eskandari 2018 Children's Remainder Trust, Dated 9/25/2018

Disclosed balance after: 218,223

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:33 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
OtherCommon Stock 193,973 $0.00 $0.00
Disclosure

SEC source: 0001753159-25-000006 · wk-form4_1765420401.xml · nonDerivative · entry 2

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares held by AmirAli Talasaz 2018 Children's Remainder Trust, Dated 9/25/2018

Disclosed balance after: 218,223

F1 · shares: Reflects changes in form of ownership from Talasaz Investments LP due to the transfer of shares to The AmirAli Talasaz 2018 Children's Remainder Trust dated 9/25/2018, and Maryam Eskandari 2018 Children's Remainder Trust, dated 9/25/2018.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:33 UTC
Talasaz AmirAliDirector · Co-Chief Executive Officer
OtherCommon Stock 387,946 $0.00 $0.00
Disclosure

SEC source: 0001753159-25-000006 · wk-form4_1765420401.xml · nonDerivative · entry 1

Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares held by Talasaz Investments, L.P.

Disclosed balance after: 82,854

F1 · shares: Reflects changes in form of ownership from Talasaz Investments LP due to the transfer of shares to The AmirAli Talasaz 2018 Children's Remainder Trust dated 9/25/2018, and Maryam Eskandari 2018 Children's Remainder Trust, dated 9/25/2018.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:32 UTC
Kalia KumudChief Information Officer
SaleCommon Stock 2,000 $104.60 $209,204.20
Disclosure

SEC source: 0001927831-25-000010 · wk-form4_1765420366.xml · nonDerivative · entry 1

Kalia Kumud · CIK 0001927831 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,365

F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.58 to $104.75. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:31 UTC
Chudova DaryaChief Technology Officer
SaleCommon Stock 13,664 $105.04 $1,435,226.93
Disclosure

SEC source: 0001977179-25-000008 · wk-form4_1765420294.xml · nonDerivative · entry 4

Chudova Darya · CIK 0001977179 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Chudova Family Trust

Disclosed balance after: 54,480

F3 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.24. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:31 UTC
Chudova DaryaChief Technology Officer
SaleCommon Stock 9,271 $106.00 $982,752.89
Disclosure

SEC source: 0001977179-25-000008 · wk-form4_1765420294.xml · nonDerivative · entry 3

Chudova Darya · CIK 0001977179 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,463

F2 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.11. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:31 UTC
Chudova DaryaChief Technology Officer
OtherCommon Stock 68,144 $0.00 $0.00
Disclosure

SEC source: 0001977179-25-000008 · wk-form4_1765420294.xml · nonDerivative · entry 2

Chudova Darya · CIK 0001977179 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Chudova Family Trust

Disclosed balance after: 68,144

Read SEC document
December 08, 2025 Filed Dec 11, 2025 02:31 UTC
Chudova DaryaChief Technology Officer
OtherCommon Stock 68,144 $0.00 $0.00
Disclosure

SEC source: 0001977179-25-000008 · wk-form4_1765420294.xml · nonDerivative · entry 1

Chudova Darya · CIK 0001977179 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,734

F1 · shares: Reflects changes in form of ownership from direct to indirect due to transfer of shares to The Chudova Family Trust.

Read SEC document
December 08, 2025 Filed Jan 22, 2026 22:42 UTC
Chudova DaryaChief Technology Officer
OtherCommon Stock 44,942 $0.00 $0.00
Disclosure

SEC source: 0001977179-26-000004 · wk-form5_1769121738.xml · nonDerivative · entry 2

Chudova Darya · CIK 0001977179 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,370

F1 · shares: Reflects changes in form of ownership from direct to indirect due to transfer of shares to The Chudova Family Trust. Incorrect number of shares reported back on Form 4 dated 12/8/2025, filed 12/10/2025.

Read SEC document
December 08, 2025 Filed Jan 22, 2026 22:42 UTC
Chudova DaryaChief Technology Officer
OtherCommon Stock 44,942 $0.00 $0.00
Disclosure

SEC source: 0001977179-26-000004 · wk-form5_1769121738.xml · nonDerivative · entry 1

Chudova Darya · CIK 0001977179 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Chudova Family Trust

Disclosed balance after: 9,538

F1 · shares: Reflects changes in form of ownership from direct to indirect due to transfer of shares to The Chudova Family Trust. Incorrect number of shares reported back on Form 4 dated 12/8/2025, filed 12/10/2025.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 02:37 UTC
Freeman ChrisChief Commercial Officer
SaleCommon Stock 2,964 $106.71 $316,282.81
Disclosure

SEC source: 0001871615-25-000008 · wk-form4_1765247852.xml · nonDerivative · entry 11

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,987

F11 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.500 to $106.990. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 02:37 UTC
Freeman ChrisChief Commercial Officer
SaleCommon Stock 400 $105.99 $42,394.52
Disclosure

SEC source: 0001871615-25-000008 · wk-form4_1765247852.xml · nonDerivative · entry 10

Freeman Chris · CIK 0001871615 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,951

F10 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.415 to $106.390. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.